OZABIO marked a powerful presence at Vitafoods Europe 2025, the world’s leading exhibition for nutraceutical innovation. As a global meeting point for scientific advancement, ingredient innovation, and market-leading brands, the event provided an exceptional platform to showcase the future of high-performance nutrition.
At the forefront of our presentation was LIPOZA, OZABIO’s advanced liposomal delivery platform—engineered to redefine how nutrients are absorbed, protected, and delivered. Our solutions attracted strong interest from international partners seeking next-generation formulations with superior bioavailability, enhanced stability, and measurable efficacy.
Vitafoods Europe 2025 enabled OZABIO to:
● Build connections with key global stakeholders and decision-makers
● Showcase cutting-edge liposomal innovations to a highly specialized audience
● Explore collaborations across Europe, North America, and emerging markets
● Engage in high-level discussions on future trends, regulatory evolution, and consumer expectations
Our participation reinforced OZABIO’s position as a forward-thinking, innovation-driven partner for brands aiming to lead in a competitive global landscape.
More than just an exhibition, Vitafoods Europe was a platform for OZABIO to demonstrate its commitment to scientific excellence and continuous innovation. By aligning our technology with global market needs, we continue to empower brands to create differentiated, high-impact nutraceutical products.
Phone: +91 78769 66742, +1 (571)315-3939, +971 52 156 2603
Mail: [email protected]
Location: 1207 Delaware Ave #2877, Wilmington DE 19806, USA
© 2026 OzaBio | All Rights Reserved.
Dynamic Light Scattering (DLS) is employed to evaluate the particle size distribution and polydispersity of liposomal formulations, providing essential information on colloidal stability, dispersion uniformity, and potential bioavailability.
For example – Lipoza®-Curcumin
Caco-2 studies utilize human intestinal epithelial cell monolayers to evaluate the permeability and predicted absorption of test substances across the gut barrier.
For example – Lipoza-Glutathione
Demonstrated superior permeability, showing 0.95% transport compared to 0.29% for Reduced L-Glutathione—an approximate 3.28-fold increase. This enhanced permeability, despite lower glutathione content, indicates improved intestinal absorption and supports its potential as a more bioavailable form of glutathione supplementation.
Fill out the form below and we'll get back to you soon
* indicates required question